Bank of New York Mellon »

Benitec Biopharma shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-09-30 $477k 34k 14.03
2025-06-30 $374k 32k 11.70

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cl A (GOOGL)
Alphabet CL C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Mastercard Inc - A Cl A (MA)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
Vanguard Group
BlackRock
Nantahala Capital Management
Infinitum Asset Management
Geode Capital Management
Silverarc Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Goldman Sachs Group
AWM Investment Company
Ameriprise Financial

View all funds holding Benitec Biopharma